InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Meek David D., 董事. Director active across 4 companies, notably Mirati Therapeutics, Inc.. Aggregated, 15 filings have been recorded. Split: 0 buy · 5 sells. Total volume traded: €178k. History available since 14 January 2022. The latest transaction was disclosed on 20 June 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Meek David D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
2,112 股@ US$14.45100.0% 占其流量Ordinary SharesSEC:0000904454-25-000328:0
7,970 股0Ordinary SharesSEC:0000904454-25-000305:0
8,080 股0Ordinary SharesSEC:0000904454-24-000403:0
2,229 股@ US$5.1239.5% 占其流量Ordinary SharesSEC:0000904454-24-000373:0
8,700 股0Ordinary SharesSEC:0000904454-23-000398:0
389 股@ US$19.7127.0% 占其流量Ordinary SharesSEC:0000899243-23-006571:0
89,379 股0Common StockSEC:0001214659-23-001042:0
3,179 股@ US$42.3764100.0% 占其流量Common StockSEC:0001214659-23-000810:0
35,425 股0Common StockSEC:0001214659-22-015198:0
22,000 股@ US$2.20100.0% 占其流量Common StockSEC:0001104659-22-078797:0
9,080 股0Ordinary SharesSEC:0000904454-22-000352:0
602 股@ US$16.7033.4% 占其流量Ordinary SharesSEC:0000904454-22-000215:0
1,534 股0Ordinary SharesSEC:0000904454-22-000193:0
27,500 股0Common StockSEC:0001104659-22-005415:0
34,057 股0Common StockSEC:0001214659-22-000844:0
15 条申报中的 15 条
About Meek David D.
Meek David D. is Directeur Général et Administrateur. He is linked to uniQure N.V. as Director, to Mirati Therapeutics, Inc. as Chief Executive Officer, and to Entasis Therapeutics Holdings Inc. as Director. Across 15 filings in total, the 15 most recent filings we hold run from 2022-01-18 to 2025-06-24, with sum_buy_eur at 0 and sum_sell_eur at 177780.
